Legal & General Group
NVS icon

Legal & General Group’s Novartis NVS Stock Holding History

Legal & General Group’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-65,156
Closed -$7.88M – 3438
2025
Q2 		$7.88M Buy
65,156
+14,073
+28% +$1.59M ﹤0.01% 1323
2025
Q1 		$5.69M Buy
51,083
+46,497
+1,014% +$4.95M ﹤0.01% 1462
2024
Q4 		$446K Buy
4,586
+339
+8% +$36.1K ﹤0.01% 2494
2024
Q3 		$488K Buy
4,247
+123
+3% +$14K ﹤0.01% 2467
2024
Q2 		$439K Sell
4,124
-832
-17% -$83.5K ﹤0.01% 2461
2024
Q1 		$479K Buy
+4,956
New +$508K ﹤0.01% 2444
2023
Q2 		– Sell
-194
Closed -$17.8K – 3480
2023
Q1 		$17.8K Sell
194
-17,275
-99% -$1.51M ﹤0.01% 3096
2022
Q4 		$1.58M Buy
17,469
+3,523
+25% +$297K ﹤0.01% 1977
2022
Q3 		$1.06M Buy
13,946
+1,247
+10% +$103K ﹤0.01% 2124
2022
Q2 		$1.07M Sell
12,699
-252
-2% -$22.1K ﹤0.01% 2140
2022
Q1 		$1.14M Buy
+12,951
New +$1.12M ﹤0.01% 2204
2015
Q4 		– Sell
-1,562
Closed -$129K – 2804
2015
Q3 		$129K Hold
1,562
– – ﹤0.01% 1901
2015
Q2 		$138K Hold
1,562
– – ﹤0.01% 1907
2015
Q1 		$138K Hold
1,562
– – ﹤0.01% 1844
2014
Q4 		$130K Hold
1,562
– – ﹤0.01% 1798
2014
Q3 		$132K Hold
1,562
– – ﹤0.01% 1720
2014
Q2 		$127K Hold
1,562
– – ﹤0.01% 1282
2014
Q1 		$119K Hold
1,562
– – ﹤0.01% 1258
2013
Q4 		$113K Hold
1,562
– – ﹤0.01% 1273
2013
Q3 		$107K Sell
1,562
-10,943
-88% -$724K ﹤0.01% 1264
2013
Q2 		$792K Buy
+12,505
New +$814K ﹤0.01% 932

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Legal & General Group's NVS Position: Q3 2025 in Review

Legal & General Group sold out of Novartis (NVS) in Q3 2025, closing a stake of 65,156 shares — an estimated $7.88M sold.

Legal & General Group first reported a position in NVS in Q2 2013 and held it in 21 quarters. The position peaked at $7.88M in Q2 2025. 1,402 funds tracked by Wall St. Rank hold NVS as of Q3 2025.

  • Legal & General Group reported no remaining Novartis position as of Q3 2025 after selling out during the quarter.
  • Legal & General Group sold 65,156 Novartis shares in Q3 2025, an estimated $7.88M.
  • Legal & General Group first reported a position in Novartis in Q2 2013 and held it in 21 quarters.
  • Legal & General Group's Novartis position peaked at $7.88M in Q2 2025.
  • 1,402 funds tracked by Wall St. Rank held Novartis as of Q3 2025.

Based on Legal & General Group's 13F filing for Q3 2025, filed 13 Nov 2025.